Pain Medicine, Interventional Pain Medicine · Montgomery, AL
NPI
1467603670
Since 2008
Specialty
Pain Medicine, Interventional Pain Medicine
Code 208VP0014X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
488 Saint Lukes Dr
Montgomery, AL, 36117
Phone (334) 288-7808
Groups this clinician bills Medicare through
Medicare paid, 2024
$665K
59,059 services
Medicare patients, 2024
589
Average age 69
Drug cost, 2024
$754K
25,429 prescriptions
Company payments, 2025
$1,981
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jacob A Vella was code J1010 (injection, methylprednisolone acetate, 1 mg), 46,135 times for 279 patients. In total Jacob A Vella billed 59,059 services in 61 codes, and Medicare paid $665K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-06-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 46,135 | 279 | $0.10 | $4,653 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,842 | 98 | $0.09 | $165 |
| 99214 Office E&M - Established | Office | 1,836 | 425 | $86.10 | $158K |
| J2250 Injection, midazolam hydrochloride, per 1 mg | Office | 1,650 | 240 | $0.11 | $174 |
| 80307 Drug Tests | Office | 670 | 333 | $57.80 | $39K |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 587 | 304 | $152.98 | $90K |
| 62323 Nerve Block Injection - Back | Office | 283 | 161 | $168.86 | $48K |
| 99443 Telephone Services | Office | 155 | 102 | $88.02 | $14K |
| 62321 Nerve Block Injection - Back | Office | 150 | 79 | $174.01 | $26K |
| J1040 Injection, methylprednisolone acetate, 80 mg | Office | 146 | 125 | $7.05 | $1,029 |
| 64636 Destruction by Neurolytic Agent - Back | Office | 127 | 99 | $230.92 | $29K |
| 64635 Destruction by Neurolytic Agent - Back | Office | 120 | 101 | $428.35 | $51K |
| 77002 Imaging - Miscellaneous | Office | 114 | 56 | $74.82 | $8,529 |
| 64493 Nerve Block Injection - Back | Office | 107 | 63 | $174.31 | $19K |
| 64494 Nerve Block Injection - Back | Office | 102 | 61 | $94.64 | $9,654 |
By year: 2022 $612K for 17,158 services; 2023 $687K for 11,751 services; 2024 $665K for 59,059 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80307 Drug Tests | 670 | 333 | $57.80 | $39K |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 587 | 304 | $152.98 | $90K |
| G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 55 | 46 | $81.68 | $4,493 |
Medicare prescription drug claims, 2024
In 2024, the drug Jacob A Vella prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 4,758 prescriptions and refills. In total Jacob A Vella wrote 25,429 Medicare prescriptions that cost $754K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 4,758 | 4,764 | 766 | $83K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 4,039 | 4,040 | 563 | $123K |
| Gabapentin Generic | 3,300 | 3,364 | 569 | $38K |
| Pregabalin Generic | 2,515 | 2,556 | 419 | $41K |
| Tizanidine Hcl Generic | 1,694 | 1,811 | 294 | $14K |
| Baclofen Generic | 1,260 | 1,358 | 261 | $9,710 |
| Cyclobenzaprine Hcl Generic | 1,205 | 1,209 | 222 | $9,756 |
| Amitriptyline Hcl Generic | 939 | 999 | 180 | $6,620 |
| Acetaminophen-Codeine Acetaminophen With Codeine | 819 | 821 | 270 | $8,746 |
| Methocarbamol Generic | 778 | 798 | 185 | $7,424 |
| Tramadol Hcl Generic | 570 | 571 | 124 | $4,318 |
| Diclofenac Sodium Generic | 476 | 510 | 104 | $11K |
| Meloxicam Generic | 405 | 409 | 80 | $1,161 |
| Lidocaine Generic | 357 | 364 | 66 | $27K |
| Morphine Sulfate Er Morphine Sulfate | 259 | 259 | 49 | $8,580 |
Brand drugs: 560 claims; generic drugs: 24,869 claims; opioid claims: 11,140.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jacob A Vella $1,981 ($1,981 in general payments such as food, travel and fees) from 10 companies. The largest payer was Abbott Laboratories with $1,229.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 46 | $1,229 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 18 | $294 |
| Akebia Therapeutics Inc AKBA | 1 | $124 |
| Si-Bone, Inc. SIBN | 1 | $116 |
| Collegium Pharmaceutical, Inc. COLL | 4 | $83.19 |
| Curonix LLC | 2 | $46.63 |
| Hologic Sales and Service, LLC HOLX | 1 | $32.46 |
| Saluda Medical Americas, Inc. | 1 | $25.8 |
| Nalu Medical, Inc. | 1 | $16.94 |
| Boston Scientific Corporation BSX | 1 | $13.64 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.